Key Takeaways
- Investor sentiment often lags fundamental shifts. The disproportionate focus on a stock’s decline, a classic sign of loss aversion, can blind market participants to underlying operational improvements or deteriorations.
- Both SoFi Technologies and Oscar Health recently achieved profitability for the first time, marking a significant inflection point for two companies previously defined by cash burn. This reality contrasts sharply with older market narratives.
- Oscar Health’s recent stock performance has been robust, driven by a vastly improved Medical Loss Ratio, challenging the premise that the stock is in a sustained pullback. Investor chatter may not have fully absorbed this operational turnaround.
- SoFi’s stock has languished despite achieving consecutive quarters of GAAP profitability, suggesting the market is weighing other factors, such as net interest margin compression and the quality of its loan book, more heavily.
- The primary risk for investors is not just emotional bias, but anchoring to outdated theses. The ability to update one’s view in the face of new data is paramount when fundamentals and sentiment diverge.
An astute observation was recently shared by the analyst ‘TheLongInvest’, who noted a period where a sharp rally in SoFi Technologies ($SOFI) received far less attention than a concurrent pullback in Oscar Health ($OSCR). This highlighted a well-documented behavioural flaw: unrealised losses command a far greater share of our mental real estate than equivalent gains. However, while this psychological quirk remains a market constant, the fundamental realities for these two firms have since evolved dramatically, presenting a more complex and perhaps more instructive case study about the dangerous lag between market sentiment and corporate performance.
The core premise of loss aversion, where the pain of losing is psychologically about twice as powerful as the pleasure of gaining, certainly explained the dynamic at the time. Yet, a dispassionate review of their recent progress reveals a narrative that has almost completely inverted. Both firms have crossed the Rubicon into profitability, but their subsequent market receptions tell very different stories, suggesting the market’s emotional biases are now clashing with fresh data.
A Tale of Two Turnarounds
For years, both SoFi and Oscar Health operated under the typical disruptor mandate: pursue growth at all costs, with profitability being a distant concern. This made them quintessential story stocks, sensitive to prevailing risk appetite. The narrative, however, is no longer theoretical. Both companies have recently delivered their first profitable quarters, a pivotal moment that the market appears to be digesting in profoundly different ways.
SoFi: Profitability Meets Scepticism
SoFi achieved its first quarter of GAAP net income in Q4 2023, a landmark event for the fintech that it repeated in Q1 2024. This transition from a cash-burning growth engine to a profitable financial institution should, in theory, have triggered a significant re-rating. Yet the stock has struggled for traction throughout much of 2024.
The market’s hesitation appears rooted in second-order concerns. While the headline profitability is welcome, analysts are scrutinising the underlying drivers. Questions linger around the sustainability of its Net Interest Margin (NIM) in a shifting rate environment and the credit quality of its personal loan portfolio. The market seems to be saying that achieving profitability was the first step, but proving its durability and quality is the next, more difficult, hurdle.
| SoFi Technologies ($SOFI) | Q4 2023 | Q1 2024 |
|---|---|---|
| Total Revenue (Adjusted) | $594.25 Million | $580.65 Million |
| GAAP Net Income | $47.9 Million | $88.0 Million |
| New Members | 585,000 | 622,000 |
Source: SoFi Technologies Q4 2023 & Q1 2024 Earnings Releases.
Oscar Health: From Punchline to Performance
Conversely, Oscar Health, long plagued by concerns over its business model and high cash burn, delivered a stunning turnaround. In Q1 2024, the company reported its first-ever profitable quarter, driven by a dramatic improvement in its Medical Loss Ratio (MLR), which fell to 74.2%. For an insurer, the MLR is a critical measure of discipline and operational efficiency, and this result signalled a fundamental shift in the business.
Unlike SoFi, Oscar’s positive operational surprise was met with a robust rally in its stock price. The market, which had seemingly priced Oscar for perpetual struggle, was forced to rapidly re-evaluate. The very ‘noise’ and negativity that once dominated the conversation may have created the conditions for a powerful rebound once the facts changed. The focus on its prior losses made the eventual turn to profit all the more impactful.
| Oscar Health ($OSCR) | Q4 2023 | Q1 2024 |
|---|---|---|
| Total Revenue | $1.46 Billion | $2.1 Billion |
| Net Income / (Loss) | ($48.6 Million) | $177.4 Million |
| Medical Loss Ratio | 88.8% | 74.2% |
Source: Oscar Health Q4 2023 & Q1 2024 Earnings Releases.
Revisiting the Lesson
The original observation that losses shout louder than gains remains valid as a general principle of human psychology. However, this case study provides a more nuanced, actionable lesson. The real danger is not just the emotional response to price changes, but the failure to update one’s core thesis when the underlying evidence shifts.
The negative sentiment surrounding Oscar became an outdated anchor point the moment its MLR demonstrated a structural improvement. Similarly, the long-standing bullish narrative for SoFi as a fintech disruptor is now being tested by the more mundane realities of banking economics. The market is looking past the “disruptor” label and applying the rigorous scrutiny of a mature financial entity.
For portfolio managers and analysts, the implication is clear. Sentiment can be a useful contrary indicator, but only when cross-referenced with fundamental velocity. The initial pain of Oscar’s decline was a distraction from the operational fixes happening beneath the surface. The initial excitement of SoFi’s growth story is now giving way to a more sober analysis of its profitability drivers. The most significant unrealised loss, it turns out, is the one incurred by clinging to an old story when the facts have written a new chapter.
References
@TheLongInvest. (2024, July 14). [Observation on the disparate market attention between SOFI’s gain and OSCR’s pullback]. Retrieved from https://x.com/TheLongInvest/status/1812480826978504938
Oscar Health, Inc. (2024, May 7). Oscar Health Announces First Quarter 2024 Results, Marking First Profitable Quarter as a Public Company. Retrieved from Oscar Health Investor Relations.
SoFi Technologies, Inc. (2024, April 29). SoFi Technologies Reports First Quarter 2024 Results. Retrieved from SoFi Investor Relations.
SoFi Technologies, Inc. (2024, January 29). SoFi Technologies Reports Fourth Quarter and Full-Year 2023 Results. Retrieved from SoFi Investor Relations.
